The scheme was tied to the Hope Clinic and involved prescribing oxycodone and other controlled substances that weren't for legitimate medical purposes from 2010 to 2015.
Many in extra vulnerable patient cohorts, like those with heart disease and diabetes, don't realize they're at elevated risk of experiencing severe disease. What can doctors and pharmacists do to help?
With an ongoing phase 3 study, pralsetinib seems to be a promising candidate for the treatment of different types of cancer because of the presence of oncogenic rearranged during transfection) fusions.
The College of Physicians and Surgeons of Nova Scotia rejected Dr. Franklyn Vincent's assertion that a letter he wrote a patient's lawyer revealing "shocking information" about the patient's condition was merely intended to correct inaccuracies.
The pharmacist in charge's failures resulted in, among other things, a relief pharmacist scrambling to future out how to obtain an opioid antagonist maintenance treatment permit while patients waited at the pharmacy for the treatment.
